Volume 7, Number 3—June 2001
Research
Melioidosis: An Emerging Infection in Taiwan?
Po-Ren Hsueh*, Lee-Jene Teng*, Li-Na Lee*†, Cheong-Ren Yu*, Pan-Chyr Yang*, Shen-Wu Ho*†, and Kwen-Tay Luh*
Table 2
Susceptibilities and antibiotypes of 17 isolates of Burkholderia pseudomallei isolated in Taiwan from November 1996 to January 2000
| MIC (μg/mL) a |
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient no./isolate | AM | AMC | PZP | CTX | CAZ | FEP | FLO | ATM | IPM | MEM | AN | CIP | TRO | MOX | Antibiotic type |
| 8/A | 64 | 8 | 0.5 | 4 | 4 | 16 | 128 | 16 | 0.5 | 1 | 64 | 2 | 2 | 2 | I |
| 9/B | 64 | 8 | 1 | 4 | 4 | 16 | 128 | 16 | 0.5 | 1 | 128 | 2 | 2 | 2 | I |
| 10/C1, 2 | 64 | 8 | 0.5 | 4 | 4 | 16 | 128 | 16 | 0.5 | 1 | 32 | 1 | 2 | 2 | II |
| 11/D1, 2, 3, 4, 5 | 64 | 8 | 0.5 | 2 | 1 | 16 | 128 | 16 | 0.5 | 1 | 32 | 2 | 4 | 1 | III |
| 12/E1, 2 | 64 | 8 | 0.5 | 2 | 1 | 8 | 128 | 16 | 0.5 | 1 | 32 | 2 | 4 | 1 | III |
| 13/F1, 2, 3 | 64 | 8 | 0.5 | 2 | 1 | 16 | 128 | 16 | 0.5 | 1 | 16 | 2 | 4 | 1 | III |
| 14/G | 16 | 2 | 0.12 | 2 | 1 | 8 | 64 | 8 | 0.25 | 0.5 | 64 | 1 | 1 | 1 | IV |
| 15/H1, 2 | 64 | 8 | 1 | 16 | 32 | 64 | 128 | 32 | 0.5 | 2 | >256 | 4 | 8 | 4 | V |
aAM, amoxicillin; AMC, amoxicillin-clavulanate; PZP, piperacillin-tazobactam; CTX, cefotaxime; CAZ, ceftazidime; FEP, cefepime; FLO, flomoxef; ATM, aztreonam; IPM, imipenem; MEM, meropenem; AN, amikacin; CIP, ciprofloxacin; TRO, trovafloxacin; MOX, moxifloxacin.
